Grants and Contributions:
Title:
Finance resource 2021
Agreement Number:
972823
Agreement Value:
$35,000.00
Agreement Date:
Jul 6, 2021 - Mar 31, 2022
Description:
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Ripple has a a number of candidate pipeline products in development and a business development and accounting resource is needed to perform market research on pipeline and partnering opportunities and ensure key metrics are appropriately recorded and analyzed on our programs.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2021-2022-Q1-972823
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
760459073
Recipient Type:
For-profit organization
Recipient's Operating Name:
Ripple Therapeutics
Recipient's Legal Name:
Ripple Therapeutics Corp.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Youth Employment Program
Program Purpose:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Coverage:
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541